Home > Insider Trading > Filing (0001179110-14-008682)

Filing Details

Accession Number:: 0001179110-14-008682
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-16 17:47:00
Reporting Period:: 2014-05-14

Filing Date:: 2014-05-16
Accepted Time:: 2014-05-16 17:47:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286370	R Michael Minogue	C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923	President, Ceo, Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $.01 Par Value	Acquisiton	2014-05-14	24,500	$0.00	265,345	No	4	A	Direct
Common Stock $.01 Par Value	Disposition	2014-05-15	4,433	$20.94	260,912	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2014-05-14	85,000	$0.00	85,000	$21.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
85,000	2015-05-14	2024-05-14	No	4	A	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$13.57	2007-06-01	2016-06-01	246,383	246,383	Direct
Common Stock	Stock Option (right to buy)	$11.27	2008-05-30	2017-05-30	85,000	85,000	Direct
Common Stock	Stock Option (right to buy)	$13.80	2009-05-23	2018-05-23	43,333	43,333	Direct
Common Stock	Stock Option (right to buy)	$18.63	2009-06-15	2018-08-13	93,750	93,750	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	109,500	108,800	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	108,800	73,000	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-03-31	2019-05-28	130,500	130,500	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	105,000	105,000	Direct
Common Stock	Stock Option (Right to Buy)	$22.44	2013-05-22	2022-05-22	100,000	100,000	Direct
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2024-05-14	85,000	85,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-06-01	246,383	246,383	Direct
2017-05-30	85,000	85,000	Direct
2018-05-23	43,333	43,333	Direct
2018-08-13	93,750	93,750	Direct
2019-05-28	109,500	108,800	Direct
2019-05-28	108,800	73,000	Direct
2019-05-28	130,500	130,500	Direct
2020-06-03	105,000	105,000	Direct
2022-05-22	100,000	100,000	Direct
2024-05-14	85,000	85,000	Direct

Footnotes

Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
These options become exercisable based on the achievement of certain performance milestones.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $20.6200 and $21.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Sale of common stock pursuant to reporting owner's 10b5-1 plan sold to pay tax obligations upon vesting.
Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 14, 2015, May 14, 2016 and May 14, 2017, so long as the reporting person continues to be employed by the issuer on the vesting dates.
In addition, performance share awards of up to 61,500 restricted units were granted to this reporting person on May 14, 2014. The number of restricted stock units that will become eligible for vesting pursuant to this award will be determined based on the issuer's fiscal 2015 financial performance. One third of the restricted stock units that become eligible for vesting will vest on the date the issuer first publicly announces its financial results for fiscal 2015. The remaining restricted stock units that become eligible for vesting will vest and the underlying shares will be delivered to the reporting person in equal tranches on each of May 14, 2016 and May 14, 2017, in all cases, so long as the reporting person continues to be employed by the issuer on the vesting dates.
In addition, performance share awards of up to 80,000 restricted units were granted to this reporting person on May 14, 2014. One half of these restricted stock units will vest immediately upon the issuer's achievement of certain regulatory milestones within three years of the date of grant, with the remaining vesting on the first anniversary of such achievement.
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.